Skip to main content
Erschienen in: Pediatric Nephrology 8/2022

03.02.2022 | Clinical Quiz

An adolescent with newly diagnosed diabetes mellitus presenting with edema: Answers

verfasst von: Ashna Pudupakkam, Faris Hashim, Matthew Stephen, Stephanie Blasick

Erschienen in: Pediatric Nephrology | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Excerpt

1.
What is the most likely diagnosis?
Insulin edema is the most likely diagnosis for this patient given the rapid onset of generalized edema following the initiation of an insulin regimen.
 
2.
What are alternative diagnoses to consider?
Alternative conditions that may initially present with generalized edema and weight gain include congestive heart failure, hepatic disease, and nephrotic syndrome. Other causes of volume overload must be excluded before making a diagnosis of insulin edema. In this case, there were no signs on physical exam to suggest cardiac or hepatic disease. Nephrotic syndrome was ruled out as the patient did not have proteinuria.
 
3.
What is the treatment of this condition?
Conservative treatment is recommended with salt and fluid restriction and the use of diuretics as needed. Most reported cases were noted to self-resolve within a few days to a few weeks. Our patient continued to have edema at follow-up with more tightness in her legs and an additional weight gain of 5 kg (69 kg, 83rd percentile, z-score up to 0.96). Although this might be attributed to expected weight gain from insulin treatment, we did not have previous growth charts to compare with her weight before diagnosis.
 
Literatur
1.
Zurück zum Zitat Chelliah A, Burge MR (2004) Insulin edema in the twenty-first century: a review of the existing literature. J Invest Med 52:104–108CrossRef Chelliah A, Burge MR (2004) Insulin edema in the twenty-first century: a review of the existing literature. J Invest Med 52:104–108CrossRef
2.
Zurück zum Zitat Hursh BE, Dedhar A, Panagiotopoulos C (2014) Case 2: generalized swelling in a child with newly diagnosed diabetes mellitus. Paediatr Child Health 19:233–234CrossRef Hursh BE, Dedhar A, Panagiotopoulos C (2014) Case 2: generalized swelling in a child with newly diagnosed diabetes mellitus. Paediatr Child Health 19:233–234CrossRef
3.
Zurück zum Zitat Bulus AD, Andiran N, Köksal AO (2016) Insulin edema in type 1 diabetes mellitus: report of a case and brief review of the literature. Iran J Pediatr 26:e5077 Bulus AD, Andiran N, Köksal AO (2016) Insulin edema in type 1 diabetes mellitus: report of a case and brief review of the literature. Iran J Pediatr 26:e5077
4.
Zurück zum Zitat Sawalha N, Geddie H (2021) Insulin edema associated with newly diagnosed type 1 diabetes and high glycated hemoglobin: a case and review of the pediatric literature. Can J Diabetes 45:571–574CrossRef Sawalha N, Geddie H (2021) Insulin edema associated with newly diagnosed type 1 diabetes and high glycated hemoglobin: a case and review of the pediatric literature. Can J Diabetes 45:571–574CrossRef
5.
Zurück zum Zitat Lee P, Kinsella J, Borkman M, Carter J (2007) Bilateral pleural effusions, ascites, and facial and peripheral edema in 19-year-old woman 2 weeks following the commencement of insulin lispro and detemir—an unusual presentation of insulin edema. Diabet Med 24:1282–1285CrossRef Lee P, Kinsella J, Borkman M, Carter J (2007) Bilateral pleural effusions, ascites, and facial and peripheral edema in 19-year-old woman 2 weeks following the commencement of insulin lispro and detemir—an unusual presentation of insulin edema. Diabet Med 24:1282–1285CrossRef
6.
Zurück zum Zitat Wong M, Balakrishnan T (2020) Anasarca in newly diagnosed type 1 diabetes: a review of the pathophysiology of insulin edema. Cureus 12:e7234PubMedPubMedCentral Wong M, Balakrishnan T (2020) Anasarca in newly diagnosed type 1 diabetes: a review of the pathophysiology of insulin edema. Cureus 12:e7234PubMedPubMedCentral
7.
Zurück zum Zitat Farah LX, Valentini V, Pessoa TD, Malnic G, McDonough AA, Girardi AC (2016) The physiological role of glucagon-like peptide-1 in the regulation of renal function. Am J Physiol Renal Physiol 310:F123–F127CrossRef Farah LX, Valentini V, Pessoa TD, Malnic G, McDonough AA, Girardi AC (2016) The physiological role of glucagon-like peptide-1 in the regulation of renal function. Am J Physiol Renal Physiol 310:F123–F127CrossRef
8.
Zurück zum Zitat Muscogiuri G, Chavez AO, Gastaldelli A, Perego L, Tripathy D, Saad MJ ... Folli F (2008) The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention. Curr Vasc Pharmacol 6:301-312 Muscogiuri G, Chavez AO, Gastaldelli A, Perego L, Tripathy D, Saad MJ ... Folli F (2008) The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention. Curr Vasc Pharmacol 6:301-312
11.
Zurück zum Zitat Acar S, Nalbantoğlu Ö, Kırkgöz T, Özkaya B, Erkan Ö, Özkan B (2021) A rare complication of insulin therapy in a child with newly diagnosed type 1 diabetes: insulin edema. J Pediatr Res 8:506–509CrossRef Acar S, Nalbantoğlu Ö, Kırkgöz T, Özkaya B, Erkan Ö, Özkan B (2021) A rare complication of insulin therapy in a child with newly diagnosed type 1 diabetes: insulin edema. J Pediatr Res 8:506–509CrossRef
12.
Zurück zum Zitat Hopkins DF, Cotton SJ, Williams G (1993) Effective treatment of insulin-induced edema using ephedrine. Diabetes Care 16:1026–1028CrossRef Hopkins DF, Cotton SJ, Williams G (1993) Effective treatment of insulin-induced edema using ephedrine. Diabetes Care 16:1026–1028CrossRef
13.
Zurück zum Zitat Suzuki H, Fujimaki M, Nakane H, Saito I, Takeshita E, Saruta T (1985) Effect of the angiotensin-converting enzyme inhibitor, captopril (SQ14, 225), on orthostatic sodium and water retention in patients with idiopathic edema. Nephron 39:244–249CrossRef Suzuki H, Fujimaki M, Nakane H, Saito I, Takeshita E, Saruta T (1985) Effect of the angiotensin-converting enzyme inhibitor, captopril (SQ14, 225), on orthostatic sodium and water retention in patients with idiopathic edema. Nephron 39:244–249CrossRef
Metadaten
Titel
An adolescent with newly diagnosed diabetes mellitus presenting with edema: Answers
verfasst von
Ashna Pudupakkam
Faris Hashim
Matthew Stephen
Stephanie Blasick
Publikationsdatum
03.02.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 8/2022
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-022-05463-y

Weitere Artikel der Ausgabe 8/2022

Pediatric Nephrology 8/2022 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.